These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35174471)
1. Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1. Wang G; Zhuang Z; Shen S; Yang F; Jiang Z; Liu Z; Wang T; Hua L Hum Cell; 2022 May; 35(3):896-908. PubMed ID: 35174471 [TBL] [Abstract][Full Text] [Related]
2. ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity. Ali R; Alabdullah M; Miligy I; Normatova M; Babaei-Jadidi R; Nateri AS; Rakha EA; Madhusudan S Cells; 2019 Oct; 8(10):. PubMed ID: 31635307 [TBL] [Abstract][Full Text] [Related]
3. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma. Yu S; Dai J; Ma M; Xu T; Kong Y; Cui C; Chi Z; Si L; Tang H; Yang L; Sheng X; Guo J Cell Death Dis; 2019 Mar; 10(4):254. PubMed ID: 30874541 [TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240 [TBL] [Abstract][Full Text] [Related]
5. p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN. Hong SW; Moon JH; Kim JS; Shin JS; Jung KA; Lee WK; Jeong SY; Hwang JJ; Lee SJ; Suh YA; Kim I; Nam KY; Han S; Kim JE; Kim KP; Hong YS; Lee JL; Lee WJ; Choi EK; Lee JS; Jin DH; Kim TW Cell Death Differ; 2014 Jan; 21(1):146-60. PubMed ID: 24141722 [TBL] [Abstract][Full Text] [Related]
6. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis. Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829 [TBL] [Abstract][Full Text] [Related]
7. E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation. Su D; Ding C; Wang R; Qiu J; Liu Y; Tao J; Luo W; Weng G; Yang G; Zhang T Free Radic Biol Med; 2024 Aug; 221():136-154. PubMed ID: 38763208 [TBL] [Abstract][Full Text] [Related]
8. PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway. Zheng F; Zhong J; Chen K; Shi Y; Wang F; Wang S; Tang S; Yuan X; Shen Z; Tang S; Xia D; Wu Y; Lu W J Exp Clin Cancer Res; 2023 Nov; 42(1):295. PubMed ID: 37940999 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells. Zhang Y; Lu Y; Xu Y; Le Z; Liu Y; Tu W; Liu Y Life Sci; 2023 May; 321():121594. PubMed ID: 36934971 [TBL] [Abstract][Full Text] [Related]
10. RBCK1, an E3 ubiquitin ligase, interacts with and ubiquinates the human pregnane X receptor. Rana R; Coulter S; Kinyamu H; Goldstein JA Drug Metab Dispos; 2013 Feb; 41(2):398-405. PubMed ID: 23160820 [TBL] [Abstract][Full Text] [Related]
11. Anti-oncogenic PTEN induces ovarian cancer cell senescence by targeting P21. Ke X; Li L; Li J; Zheng M; Liu P Cell Biol Int; 2022 Jan; 46(1):118-128. PubMed ID: 34643308 [TBL] [Abstract][Full Text] [Related]
12. The HECT family of E3 ubiquitin ligases and PTEN. Song MS; Pandolfi PP Semin Cancer Biol; 2022 Oct; 85():43-51. PubMed ID: 34129913 [TBL] [Abstract][Full Text] [Related]
13. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Zhang M; Tian Y; Wang RP; Gao D; Zhang Y; Diao FC; Chen DY; Zhai ZH; Shu HB Cell Res; 2008 Nov; 18(11):1096-104. PubMed ID: 18711448 [TBL] [Abstract][Full Text] [Related]
14. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation. Ahmed SF; Deb S; Paul I; Chatterjee A; Mandal T; Chatterjee U; Ghosh MK J Biol Chem; 2012 May; 287(19):15996-6006. PubMed ID: 22427670 [TBL] [Abstract][Full Text] [Related]
15. Identification of ubiquitin ligase activity of RBCK1 and its inhibition by splice variant RBCK2 and protein kinase Cbeta. Tatematsu K; Yoshimoto N; Okajima T; Tanizawa K; Kuroda S J Biol Chem; 2008 Apr; 283(17):11575-85. PubMed ID: 18303026 [TBL] [Abstract][Full Text] [Related]
16. Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer. Wang K; Liu J; Li YL; Li JP; Zhang R Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188723. PubMed ID: 35314212 [TBL] [Abstract][Full Text] [Related]
17. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression. Liu L; Long H; Wu Y; Li H; Dong L; Zhong JL; Liu Z; Yang X; Dai X; Shi L; Ren M; Lin Z Cell Signal; 2018 Oct; 50():90-99. PubMed ID: 29958993 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas. Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565 [TBL] [Abstract][Full Text] [Related]
19. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis. Tan M; Xu J; Siddiqui J; Feng F; Sun Y Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654 [TBL] [Abstract][Full Text] [Related]
20. Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb. Shao C; Li Z; Ahmad N; Liu X Cell Cycle; 2017 May; 16(10):957-967. PubMed ID: 28437168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]